QC testing of cytotoxic medicines
Did you know that Tentamus have specialist GMP approved facilities in the EU and the UK for the analysis of cytotoxic (cytostatic) materials and products?
(PresseBox) - In the 1940s, two prominent Yale pharmacologists, Alfred Gilman and Louis Goodman examined the therapeutic effects of mustard agents in treating lymphoma. This marked the beginning of the use of cytotoxic agents for the treatment of cancer.
Cytotoxic drugs or cytostatics are drugs used to destroy cancer cells. They act by inhibiting cell division and in this way cause cancer cells to die.
The drugs can be used to destroy tumours, boost the outcomes of surgery or radiotherapy, reduce metastases and alleviate cancer symptoms. Cytostatics can be effective outside the primary tumour and destroy small tumours that have not been detected in tests.
The use of cytotoxic drug treatment with different mechanisms of action has led to significant improvements in patient survival and a decline in mortality rates. This has been further enhanced by improved cancer screening and early detection, along with cause prevention by healthcare education.
The Tentamus Group is made up of class leading independent laboratories, providing high quality service and support to our clients worldwide. Our expertise covers a comprehensive and diverse portfolio of services to meet the fast-moving demands of the industry, through our dedicated laboratory locations in Europe, UK, Israel, China and the United States. Visit our website www.tentamus.com for more information.
If you have a requirement for testing of cytotoxic products, please contact one of our specialist GMP approved laboratories, who are specifically trained to handle cytotoxic products which are destined for market within the both the EU and UK.
Get in touch.
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 52 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food&feed, pharmaceuticals&medical, agrochemicals, cosmetics, agriculture&environment and nutraceutical&supplements). Tentamus Group is represented in over 52 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Datum: 04.04.2019 - 03:14 Uhr
Sprache: Deutsch
News-ID 1548270
Anzahl Zeichen: 3228
contact information:
Contact person:
Town:
Berlin
Phone:
Kategorie:
Energy & Utilities
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 966 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"QC testing of cytotoxic medicines
"
steht unter der journalistisch-redaktionellen Verantwortung von
Tentamus Group GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
